FDA
approval
· 2018-11-28
FDA Approved: FIRDAPSE — Original Application (Catalyst Pharmaceuticals, Inc.)
Summary
FDA approved FIRDAPSE (amifampridine phosphate) in this original application for Lambert-Eaton myasthenic syndrome, marking the drug's initial approval for the …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for FIRDAPSE (AMIFAMPRIDINE PHOSPHATE)